Daniel M. Bendheim
Exec. VP, Corporate Strategy at Phibro Animal Health Corporation
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 1 year
- Director since
- 2025
1 year of board service in total across 1 board, counting each seat separately. Longest: Phibro Animal Health Corporation, 1 year.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Phibro Animal Health Corporation November 3, 202698.1%
-
Phibro Animal Health Corporation November 6, 202395.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 6, 2026 | Phibro Animal Health Corporation | Grant or award | +11,699 | — | — |
| Aug 4, 2026 | Phibro Animal Health Corporation | Other | −486 | $36.60 | $17,788 |
| Aug 15, 2025 | Phibro Animal Health Corporation | Grant or award | +3,964 | — | — |
Questions about Daniel M. Bendheim
What boards is Daniel M. Bendheim on?
Daniel M. Bendheim sits on the board of Phibro Animal Health Corporation.
What company is Daniel M. Bendheim the CEO of?
Daniel M. Bendheim is President and CEO of Phibro Animal Health Corporation.
How long has Daniel M. Bendheim served on boards?
Our records show at least 1 year of board service across 1 board, the earliest from 2025.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.